1. Home
  2. MDGL vs MTG Comparison

MDGL vs MTG Comparison

Compare MDGL & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • MTG
  • Stock Information
  • Founded
  • MDGL 2011
  • MTG 1957
  • Country
  • MDGL United States
  • MTG United States
  • Employees
  • MDGL N/A
  • MTG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • MTG Property-Casualty Insurers
  • Sector
  • MDGL Health Care
  • MTG Finance
  • Exchange
  • MDGL Nasdaq
  • MTG Nasdaq
  • Market Cap
  • MDGL 6.8B
  • MTG 5.8B
  • IPO Year
  • MDGL N/A
  • MTG 1991
  • Fundamental
  • Price
  • MDGL $290.96
  • MTG $26.89
  • Analyst Decision
  • MDGL Strong Buy
  • MTG Hold
  • Analyst Count
  • MDGL 10
  • MTG 8
  • Target Price
  • MDGL $420.63
  • MTG $26.50
  • AVG Volume (30 Days)
  • MDGL 361.7K
  • MTG 1.7M
  • Earning Date
  • MDGL 05-01-2025
  • MTG 04-30-2025
  • Dividend Yield
  • MDGL N/A
  • MTG 1.94%
  • EPS Growth
  • MDGL N/A
  • MTG 15.33
  • EPS
  • MDGL N/A
  • MTG 3.00
  • Revenue
  • MDGL $317,383,000.00
  • MTG $1,219,604,000.00
  • Revenue This Year
  • MDGL $264.55
  • MTG $3.00
  • Revenue Next Year
  • MDGL $67.21
  • MTG $3.46
  • P/E Ratio
  • MDGL N/A
  • MTG $8.77
  • Revenue Growth
  • MDGL N/A
  • MTG 4.64
  • 52 Week Low
  • MDGL $200.08
  • MTG $20.11
  • 52 Week High
  • MDGL $377.46
  • MTG $26.56
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.85
  • MTG 67.89
  • Support Level
  • MDGL $280.00
  • MTG $26.09
  • Resistance Level
  • MDGL $307.54
  • MTG $26.77
  • Average True Range (ATR)
  • MDGL 15.97
  • MTG 0.51
  • MACD
  • MDGL -2.00
  • MTG 0.09
  • Stochastic Oscillator
  • MDGL 15.88
  • MTG 98.89

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.

Share on Social Networks: